Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: EndostarTM Injection|DRUG: Gemcitabine|DRUG: Navelbine|DRUG: Platinum|DRUG: Xeloda Tablets:
Sponsor: Xinjiang Medical University